[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100500917":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":17,"locations":10,"responsibleParty":23,"collaborators":10,"id":25,"slug":10,"hasResults":26,"nctId":27,"briefTitle":28,"officialTitle":29,"acronym":10,"eligibilityCriteria":30,"healthyVolunteers":26,"sex":31,"minAge":32,"maxAge":10,"enrollmentInfo":33,"targetDuration":10,"studyType":36,"phases":37,"briefSummary":39,"conditions":40,"keywords":10,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":10},{"fullName":5,"class":6},"Institut Paoli-Calmettes","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"collection of blood and tumor samples",null,[12],"Other: collection of blood and tumor samples",[14],{"type":6,"name":9,"description":15,"armGroupLabels":16,"otherNames":10},"The study consists of the collection of a 25 ml blood sample:\n\n* Before the start of treatment\n* Approximately 2 months after the start of induction chemotherapy\n* At the end of induction chemotherapy\n* Prior to local treatment (radiotherapy, surgery)\n* At the time of tumor progression\n\nAt the time of collection of tumor material:\n\n* During the initial diagnostic biopsy\n* On the operating room in case of surgery\n* During a tumor biopsy in case of recurrence or progression (optional) and a questionnaire evaluating the patient's spontaneous physical activities.",[9],[18],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"Dominique GENRE, MD","CONTACT","+33491223778","drci.up@ipc.unicancer.fr",{"type":24,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100500917",false,"NCT05802485","PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT","PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT: PANDORE-PANC-IPC 2021-082","Inclusion Criteria:\n\n* Non-metastatic pancreatic adenocarcinoma that is not immediately resectable (borderline and locally advanced tumors according to the NCCN 2020 classification)\n* No previous treatment with surgery or chemotherapy\n* Age \\> 18 years\n* General condition WHO 0-2 (patient whose general condition can allow medical treatment or surgery)\n* Therapeutic management at the Paoli-Calmettes Institute\n* Signature of the informed consent specific to the PANDORE-PANC study\n* Patient affiliated to a social security system or benefiting from such a system\n\nExclusion Criteria:\n\n* Metastatic disease\n* Pancreatic tumor of a histological type other than adenocarcinoma\n* Other tumor under treatment or for which treatments have been completed for \\\u003C 1 year\n* Pregnant or breastfeeding women\n* Person in an emergency situation\n* Person of legal age under legal protection (guardianship, curatorship or safeguard of justice) or unable to give consent.","ALL","18 Years",{"count":34,"type":35},300,"ESTIMATED","INTERVENTIONAL",[38],"NA","The study consists of a 25 ml blood sample collection:\n\n* Before the start of treatment\n* Approximately 2 months after the start of induction chemotherapy\n* At the end of induction chemotherapy\n* Prior to local treatment (radiotherapy, surgery)\n* At the time of tumor progression\n\nCollection of tumor material:\n\n* During the initial diagnostic biopsy\n* On the operating room in case of surgery\n* At tumor biopsy in case of recurrence or progression (optional) As well as the completion of a questionnaire at inclusion.",[41],"Pancreatic Cancer Non-resectable","NOT_YET_RECRUITING","2023-03-27",{"date":45,"type":46},"2023-04-06","ACTUAL",{"date":48,"type":35},"2023-04-30",{"date":50,"type":35},"2029-02-01",{"name":5,"class":6}]